Minerva Neurosciences (NERV) Current Leases (2019 - 2021)
Minerva Neurosciences (NERV) reported Current Leases of $16288.0 for Q2 2021, down 91.19% on a YoY basis from $184777.0 in Q2 2020, and down 74.69% quarter-over-quarter from $64350.0 in Q1 2021.
Minerva Neurosciences (NERV) Current Leases (2019 - 2021) Analysis & Trends
Minerva Neurosciences has reported Current Leases for 3 years, with the latest figure at $16288.0 in Q2 2021.
- For the quarter ending Q2 2021, Current Leases fell 91.19% year-over-year to $16288.0; the trailing twelve-month figure through Jun 2021 stood at $16288.0 (down 91.19% YoY), and the FY2020 full-year result was $111229.0, down 35.67% from the prior year.
- Current Leases for Q2 2021 stood at $16288.0, down from $64350.0 in the prior quarter.
- The five-year high for Current Leases was $184777.0 in Q2 2020, with the low at $16288.0 in Q2 2021.
- Historically, Current Leases has averaged $137020.8 across 3 years, with a median of $159279.0 in 2019.
- Annual changes were most pronounced in 2020 — Current Leases gained 14.48% — and 2021, when it sank 91.19%.
- Minerva Neurosciences' Current Leases stood at $172901.0 in 2019, then slumped by 35.67% to $111229.0 in 2020, then plunged by 85.36% to $16288.0 in 2021.
- The last three Current Leases figures came in at $16288.0 (Q2 2021), $64350.0 (Q1 2021), and $111229.0 (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Minerva Neurosciences | 197.55 Mn | 197.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 16,288.00 |
| Mar 31, 2021 | 64,350.00 |
| Dec 31, 2020 | 111,229.00 |
| Sep 30, 2020 | 156,956.00 |
| Jun 30, 2020 | 184,777.00 |
| Mar 31, 2020 | 178,765.00 |
| Dec 31, 2019 | 172,901.00 |
| Sep 30, 2019 | 167,181.00 |
| Jun 30, 2019 | 161,602.00 |
| Mar 31, 2019 | 156,159.00 |